A new technology for gene therapy could improve longevity
Elizabeth Parrish, CEO of BioViva, may finally be catching up to the science.
Gene therapy is a promising therapeutic option, but it suffers from overly high expectations. Since years, people have speculated on applications that go beyond the restoration of lost functions and include biological enhancements such as longer life. Transhumanism, which is the use of medical and surgery to improve the body or to give it additional capabilities as opposed to treating problems, has been categorized by some as gene therapy.